about
Overutilization of proton-pump inhibitors: what the clinician needs to know25 Years of Proton Pump Inhibitors: A Comprehensive Review.Proton pump inhibitors and risk of vitamin and mineral deficiency: evidence and clinical implicationsChallenges of correlating pH change with relief of clinical symptoms in gastro esophageal reflux disease: a phase III, randomized study of Zegerid versus Losec.A randomized open-label trial of on-demand rabeprazole vs ranitidine for patients with non-erosive reflux disease.Potential options to optimize therapy of gastroesophageal reflux disease with proton pump inhibitors.Strategy for treatment of nonerosive reflux disease in AsiaEarly effects of Lansoprazole orally disintegrating tablets on intragastric pH in CYP2C19 extensive metabolizersDiagnosis and management of non-erosive reflux disease--the Vevey NERD Consensus Group.The pharmacology of esomeprazole and its role in gastric acid related diseases.NERD: an umbrella term including heterogeneous subpopulations.Effective and safe proton pump inhibitor therapy in acid-related diseases - A position paper addressing benefits and potential harms of acid suppressionDistinction between patients with non-erosive reflux disease and functional heartburn.Balancing the risks and benefits of proton pump inhibitors.Reversal of the tolerance phenomenon by the intermittent administration of a histamine H2-receptor antagonist.Editorial: just how "difficult" is it to withdraw PPI treatment?Patient selection for therapy reduction after long-term daily proton pump inhibitor treatment for gastro-oesophageal reflux disease: trial and error.Perceptions and beliefs concerning gastroesophageal reflux disease: physicians and patients disagree.Radiographic Localization Study of a Novel Potassium-Competitive Acid Blocker, Vonoprazan, in the Rat Gastric Mucosa.On-Demand Therapy with Proton Pump Inhibitors for Maintenance Treatment of Nonerosive Reflux Disease or Mild Erosive Esophagitis: A Systematic Review and Meta-Analysis
P2860
Q24634086-D129EC3C-B9CE-40A8-973B-70B06C579509Q28070003-0EAF6AA3-0C72-488D-87C8-F64F2BFCA13BQ33949498-9CBA0D2C-BC8C-4DE4-944D-4018D0FFB53AQ35112456-CB75A265-DF3B-450C-B8CF-B36709C502E6Q35963755-D6FAC955-6705-4EDC-8F28-96DBFC83A6DFQ37018462-B2B450BE-26E5-48C2-B071-194B6059C432Q37174645-36B7108E-7191-4DE9-97B8-A9F08333E27FQ37240401-CF55C2CC-12EA-4748-A811-3C9F95FEE9DFQ37466737-E3D984C7-C9CD-4110-8673-EFB9DF222B9AQ37552951-8578CAB5-F24A-4610-8DDB-46BD13994CBDQ38092939-88BE15C7-7BC8-497C-9DD4-0085786F6EACQ42371575-4C6774A8-FF47-4C6D-A290-AFE07EAAFBB3Q42406587-76F77CB6-A516-437E-9140-4F4D651E8D07Q42729627-6ED270E4-16EF-42EF-8496-245333079C43Q42925045-FF34619C-0EBF-44C0-A69A-356BFC6CB178Q42981048-DCBA5298-2A46-43FC-8200-D6516142C718Q47919882-FD2E5478-F9FA-48E6-956B-D0491C1FEE8EQ48447750-E49DC01F-B01B-4E81-849F-BD6B2D5660F8Q52881408-5D384F79-3F6E-48BB-9E48-F669DF383740Q58787771-1BBC3D94-F13B-4531-AA06-7CD73A8D5D24
P2860
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
On-demand therapy for gastroesophageal reflux disease.
@ast
On-demand therapy for gastroesophageal reflux disease.
@en
type
label
On-demand therapy for gastroesophageal reflux disease.
@ast
On-demand therapy for gastroesophageal reflux disease.
@en
prefLabel
On-demand therapy for gastroesophageal reflux disease.
@ast
On-demand therapy for gastroesophageal reflux disease.
@en
P2093
P2860
P1476
On-demand therapy for gastroesophageal reflux disease.
@en
P2093
Colin W Howden
David C Metz
Peter Bytzer
Sander J Veldhuyzen van Zanten
P2860
P304
P356
10.1111/J.1572-0241.2006.00998.X
P407
P50
P577
2007-03-01T00:00:00Z